Research Projects

Subhra K. Biswas

 

As Collaboration Partner:

 

C5aR TURN

Austrian Science Fund (FWF)

Principal Investigator Project

Grant DOI 10.55776/PAT4676425

Project Lead: Doris Wilflingseder, Veterinary University of Vienna

01/09/2026 – 31/08/2030

Florian Krammer:

 

As Project Lead:

 

Development of universal influenza vaccine candidates

Austrian Science Fund (FWF)

Erwin Schrödinger

Grant DOI 10.55776/J3232

Abroad Phase: Mount Sinai School of Medicine, New York

01/12/2011 – 30/11/2013

 

Broad humoral protection induced by influenza B neuraminidase-based immunogens

National Institutes of Health (NIH)

Project Number 5R01AI117287-05, PI

Icahn School of Medicine at Mount Sinai, New York

2016 – 2020

 

Determining the induction of hemagglutinin stalk and neuraminidase antibody responses after LAIV vaccination in children

National Institutes of Health (NIH)

Project Number R21 AI151917, PI

Icahn School of Medicine at Mount Sinai, New York

2020 – 2021

 

Collaborative Influenza Vaccine Innovation Centers (CIVICs)

National Institutes of Health (NIH)

Project Number 75N93019C00051, Co-PI

Icahn School of Medicine at Mount Sinai, New York

2019 – 2024

 

Development of a vaccine candidate for Coronaviruses

National Institutes of Health (NIH)

Project Number 75N93023C00019, PI

Icahn School of Medicine at Mount Sinai, New York

2023

 

New York City Virus Hunters – A Community Science Initiative

National Institutes of Health (NIH)

Project Number R25 GM150146, Co-PI

Icahn School of Medicine at Mount Sinai, New York

2023 – 2025

 

As Collaboration Partner:

 

Toward a universal influenza virus vaccine based on live attenuated NS1-deleted influenza viruses

National Institutes of Health (NIH)

Project Number R01 AI141226

Project Lead: Adolfo Garcia-Sastre

Icahn School of Medicine at Mount Sinai, New York

2017 – 2023

 

Immunobiology of Influenza Virus-related Critical Illness in Young Hosts

National Institutes of Health (NIH)

Project Number 5R01AI154470-03

Project Lead: Adrienne G. Randolph

Boston Children’s Hospital

2020 – 2024

 

DIVINCI: Dissection of Influenza Vaccination and Infection for Childhood Immunity

National Institutes of Health (NIH)

Project Number U01 AI144616

Project Lead: Paul G. Thomas

St. Jude Children’s Research Hospital, Memphis

2019 – 2025

 

Viral Immunity and VAccination (VIVA) Human Immunology Project Consortium (HIPC)

National Institutes of Health (NIH)

Project Number U19 AI168631

Project Lead: Ana Fernandez-Sesma

Icahn School of Medicine at Mount Sinai, New York

2022 – 2026

 

Programming Long-lasting Immunity to Coronaviruses (PLUTO)

National Institutes of Health (NIH)

Project Number P01 AI172531

Project Lead: Viviana A. Simon

Icahn School of Medicine at Mount Sinai, New York

2023 – 2025

 

C5aR TURN

Austrian Science Fund (FWF)

Principal Investigator Project

Grant DOI 10.55776/PAT4676425

Project Lead: Doris Wilflingseder, Veterinary University of Vienna

01/09/2026 – 31/08/2030

 

Influenza HA and the importance of glycosylation

Austrian Science Fund (FWF)

Principal Investigator Project

Project Lead: Dieter Palmberger, University of Natural Resources and Life Sciences (BOKU), Vienna

Grant DOI 10.55776/P25092

01/11/2012 – 31/01/2017

 

Helmut Salzer

 

As Principal Investigator:

 

An interventional efficacy and safety Phase 3 double-blind 2-arm study to investigate IV followed by oral fosmanogepix compared with IV caspofungin followed by oral fluconazole in adult participants with candidemia and/or invasive candidiasis (FAST-IC)

 

Clinical study/ Industrial collaboration

Johannes Kepler University Linz

28/02/2025 – 27/02/2028

 

An interventional Phase 3, open-label, two-cohort study to investigate the efficacy and safety of fosmanogepix in adult patients with invasive mold infections caused by Aspergillus spp., Fusarium spp., Lomentospora prolificans, Mucorales fungi, or other multidrug resistant molds (FORWARD-IM)

Clinical study/ Industrial collaboration

Johannes Kepler University Linz

27/08/2025 – 26/08/2028

 

A phase 2, multicentre, open-label, single arm study to evaluate the effectiveness and safety of rezafungin (as acetate) in the treatment of chronic pulmonary aspergillosis (CPA) in patients with limited treatment options (MR907-2502)

Clinical study/ Industrial collaboration

Johannes Kepler University Linz

17/02/2026 – 16/02/2027

 

FungiScope (Global Emerging Fungal Infection Registry)

Clinical study

Johannes Kepler University Linz

27/03/2026 – 01/05/2028

 

As Project Collaboration Partner:

 

Medical Intelligence for Next Generation Diagnostics (MIND)

Regional funding

Project Lead: Medina Hamidovic, Johannes Kepler University Linz

01/04/2026 – 30/11/2027

Doris Wilflingseder:

 

As Project Lead:

 

Complement vs.IgG:HIV opsonisation determines DC modulation

Grant DOI 10.55776/P18960

Medical University of Innsbruck

01/10/2006 – 14/07/2010

 

DCs exposed to HIV-C: Key to better Vaccines?

Austrian Science Fund (FWF)

Principal Investigator Project

Grant DOI 10.55776/P22165

Medical University of Innsbruck

01/03/2010 – 30/06/2013

 

HIV Infection and Transmission close to Reality

Austrian Science Fund (FWF)

Principal Investigator Project

Grant DOI 10.55776/P24598

Medical University of Innsbruck

01/06/2012 – 31/03/2017

 

HIV-C escapes Restriction not Sensing in DCs

Austrian Science Fund (FWF)

Principal Investigator Project

Grant DOI 10.55776/P33510

Medical University of Innsbruck

01/06/2020 – 31/12/2025

 

C5aR TURN

Austrian Science Fund (FWF)

Principal Investigator Project

Grant DOI 10.55776/PAT4676425

Veterinary University of Vienna

01/09/2026 – 31/08/2030

As Collaboration Partner:

 

Replace mice xenografts by Microfluidic CancerogEnesis Chips

Austrian Science Fund (FWF)

Principal Investigator Project

Grant DOI 10.55776/P37331

Project Lead: Heinz Wanzenböck, Vienna University of Technology

01/10/2024 – 30/09/2027

 

The ATP receptor P2Y11 engages nonapoptotic functions of Fas

Austrian Science Fund (FWF)

Principal Investigator Project

Grant DOI 10.55776/P33640

Project Lead: Martin Thurnher, Medical University of Innsbruck

15/07/2020 – 14/07/2024

 

Shine the spotlight on intratumoral cDC2 and DC3

Austrian Science Fund (FWF)

Principal Investigator Project

Grant DOI 10.55776/PAT5895324

Project Lead: Patrizia Stoitzner, Medical University of Innsbruck

01/02/2025 – 31/01/2029

 

Treating SARS-CoV-2 infection in human 3D respiratory models

Austrian Science Fund (FWF)

Principal Investigator Project

Grant DOI 10.55776/P34070

Project Lead: Wilfried Posch, Medical University of Innsbruck

01/10/2020 – 30/09/2025

 

Epitope specificity of MOG antibodies

Austrian Science Fund (FWF)

Principal Investigator Project

Grant DOI 10.55776/P32699

Project Lead: Markus Reindl, Medical University of Innsbruck

01/09/2019 – 31/08/2023

 

IMPROVE (3Rs concepts to improve the quality of biomedical science)

COST Action 

Project number: CA21139

Action Chair: Dr Winfried Neuhaus, Austrian Institute of Technology

Winfried Neuhaus

21/10/2022 – 20/10/2026

Peter Willeit

 

As Project Lead:

 

Role of Micro-RNA-122 in Cardiometabolic Diseases

Austrian Science Fund (FWF)

Erwin Schrödinger

Grant DOI 10.55776/J3679

Abroad Phase: King´s College London

01/01/2015 – 31/08/2016

 

Repeat cIMT measurement for predicting cardiovascular events

Austrian Science Fund (FWF)

Principal Investigator Project

Grant DOI 10.55776/P32488

Medical University of Innsbruck

01/12/2019 – 31/05/2024

As Collaboration Partner:

 

Sex differences in the effects of cardiovascular medications

Austrian Science Fund (FWF)

Principal Investigator Project 

Grant DOI 10.55776/PAT1579524

Project Lead: Lena Manuela Tschiderer, Medical University of Innsbruck

01/03/2025 – 28/02/2029

 

Role of Afamin in cardiometabolic diseases

Austrian Science Fund (FWF)

Principal Investigator Project

Grant DOI 10.55776/PAT1570025

Project Lead: Barbara Kollerits, Medical University of Innsbruck

01/05/2026 – 30/04/2030